Robert M. Wenham
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 85
- Cancer Research top 1%
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 35
- Oncology top 2%
- PARP inhibition in cancer therapy 25
- Cancer survivorship and care 8
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 7
-
- BRCA gene mutations in cancer 17
-
- Intraperitoneal and Appendiceal Malignancies 13
-
- Cervical Cancer and HPV Research 7
- Co-authors
- Jin Q. ChengDomenico CoppolaNisha BansalPatricia A. KrukJiawang WangSanto V. NicosiaLili HeWilliam Kong
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Robert M. Wenham
149 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Reproductive Medicine 1.4k
- Cancer Research 1.4k
- Obstetrics and Gynecology 632
- Oncology 1.4k
- Molecular Biology 2.3k
Countries citing papers authored by Robert M. Wenham
This map shows the geographic impact of Robert M. Wenham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Wenham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Wenham more than expected).
Fields of papers citing papers by Robert M. Wenham
This network shows the impact of papers produced by Robert M. Wenham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Wenham. The network helps show where Robert M. Wenham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert M. Wenham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 36 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 89 | |
| 12 | 2019 | 9 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 7 | |
| 15 | 2015 | 1 | |
| 16 | 2013 | 13 | |
| 17 | 2012 | 50 | |
| 18 | A PHASE 1B STUDY OF TREBANANIB (AMG 386) IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) OR TOPOTECAN (T) IN WOMEN WITH RECURRENT OVARIAN CANCER | 2012 | 1 |
| 19 | 2009 | 7 | |
| 20 | 2009 | 65 |
About Robert M. Wenham
Robert M. Wenham is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 158 papers that have together received 4.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (85 papers), Endometrial and Cervical Cancer Treatments (35 papers), PARP inhibition in cancer therapy (25 papers), BRCA gene mutations in cancer (17 papers), Intraperitoneal and Appendiceal Malignancies (13 papers), Cancer survivorship and care (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cervical Cancer and HPV Research (7 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Cancer Research (1.4k citations) and Obstetrics and Gynecology (632 citations). Robert M. Wenham has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jin Q. Cheng, Domenico Coppola, Nisha Bansal, Patricia A. Kruk, Jiawang Wang, Santo V. Nicosia, Lili He, William Kong, Hua Yang and Jianjun Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.